Navigation Links
Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
Date:6/3/2010

h-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL). (8067) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Impact of high-risk classification by FISH on overall survival in myeloma: An Eastern Cooperative Oncology Group (ECOG) study E4A03. (10546) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL). (8053) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Neurotoxic and peripheral neuropathic effects in preclinical and clinical studies of carfilzomib (CFZ), a novel proteasome inhibitor (PI). (8135) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Rituximab, fludarabine, mitoxantrone, and dexamethasone (R-FND) for patients with relapsed indolent B-cell lymphoma (RIL). (8078) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Treatment patterns and outcome among patients with multiple myeloma relapsing and or refractory to bortezomib and immunomodulatory drugs: A multicenter International Myeloma Working Group study. (8125) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Update on vantage program to assess combined vorinostat (V) and bortezomib (B) in patients (pts) with relapsed and/or refractory (RR) multiple myeloma (MM). (8133) (General Poster Session) Saturday, June 5 from 8:00 am 12:00 p.m. in S Hall A2

  • Effect of early chemotherapy intensification with BEACOPP in high-risk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD. (8006) (Oral Abstract Session) - Saturday, June 5 from 1:00 p.m. 4:00 p.m. in E354a

    '/>"/>


  • Contact: Amy Leahing
    amy.leahing@widmeyer.com
    646-213-7245
    John Theurer Cancer Center
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Strauss Radio Strategies - The Nation's Leading Radio Media Relations Firm - Expands Government Business with Award on GSA Schedule
    2. Intellicig Clinches Exclusive Deal with Retail Distribution-Giant to Distribute Their Industry Leading Electronic Cigarettes
    3. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
    4. Leading Sales and Operations Planning (S&OP) Provider Steelwedge Announces i2 Exchange Program
    5. Mental illnesses are second leading cause of time off work in Spain
    6. The International Association of Pediatricians & Leading Physicians of the World Helps New Mothers Find Top Pediatricians in Their Area
    7. Two of Cincinnatis Leading Employee Benefit Providers Merge to Offer Clients Greater Expertise and Service
    8. NeuroFocus Adds Two More of the Worlds Leading Neuroscientists to its Advisory Board
    9. Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms
    10. Leading COPD Drug Wont Harm Heart: FDA
    11. MPE Inc., a Leading Supplier of Recycled Protective Garments, Becomes Approved Vendor on DOD EMALL
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/20/2014)... CA (PRWEB) September 20, 2014 On ... receive a $250,000 pediatric cancer research grant from Hyundai ... Loma Linda University Children’s Hospital located on 11234 Anderson ... work of Dr. Kimberley Payne, Associate Professor at Loma ... work focuses on leukemia in children. , ...
    (Date:9/20/2014)... The print component of “Work-Life Balance” is being ... with a circulation of approximately 97,000 copies and ... is distributed nationally through a vast social media ... sites and partner outlets. To explore the digital ... , The publication features an exclusive Mediaplanet interview ...
    (Date:9/20/2014)... -- The avian flu that killed 160 harbor seals ... respiratory drops and therefore poses a potential threat to ... human illnesses have been linked to the harbor seal ... discovered natural mutations to the avian H3N8 seal virus ... in droplets. Current seasonal flu vaccines wouldn,t help ...
    (Date:9/20/2014)... season is coming soon. The high-end fashion designer BellasDress is ... . A lot of sophisticated women like its new items. ... for its high quality clothes. Now, each of its elegant ... 71 percent off. , The company’s cocktail dress assortment ... many fashionable colors. Mary, the company’s sales manager, believes that ...
    (Date:9/20/2014)... September 20, 2014 New PharmaPoint ... Market Analysis to 2023?. The asthma market saw ... it has become saturated with relatively efficacious standard ... (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), and ... generic competition. However, the launch of seven novel ...
    Breaking Medicine News(10 mins):Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4
    ... American Jewish World Service (AJWS) has applauded President Barack ... U.S. funding for family planning services provided by overseas NGOs ... , , "President Obama,s decision to roll back ... believe that the only way to stop the spread of ...
    ... nation,s leading medical transcription school, provides students ... reference tool, Benchmark KB. Developed ... Documentation Integrity (AHDI) and transcription industry technology ... an extensive collection of online medical transcription ...
    ... 23 The following is a statement by ... on State Department And Foreign Operations: "President Obama ... that harms many and helps no one. ... births and reduce infant mortality, while preventing abortions, ...
    ... Fatalities have dropped 21%, while population has increased 10%, study ... are safer drivers than they were a decade ago, a ... age of 70 fell 21 percent between 1997 and 2006, ... number of those in this age group. Although the number ...
    ... decision by President Barack Obama to reverse the ... Justin Rigali, chairman of the U.S. Bishops, Committee ... after President Obama issued the executive order restoring ... abortion in developing nations. Cardinal Rigali,s statement follows."It ...
    ... he delivers his unique music and message for young cancer ... Jan. 23 Coffey Anderson has never taken his talents ... to "give back" to a worthy cause, especially one involving ... so quickly with volunteers eager to bring their own brand ...
    Cached Medicine News:Health News:AJWS Encouraged by Obama Move to Rescind Global Gag Rule 2Health News:Career Step, Leading School In Growing Health Documentation Industry, Adds Online Reference Tool 2Health News:Career Step, Leading School In Growing Health Documentation Industry, Adds Online Reference Tool 3Health News:Elderly Car Crash Deaths Down in Last Decade 2Health News:Elderly Car Crash Deaths Down in Last Decade 3Health News:Elderly Car Crash Deaths Down in Last Decade 4Health News:Country Singer Coffey Anderson to Join Celebs at Valerie Fund Event 2
    (Date:9/19/2014)... -- Alere Inc. (NYSE: ALR ), a global ... in support of President Barack Obama,s Executive ... leader in rapid diagnostics for infectious disease, we commend ... the serious threat of antibiotic resistance. We look forward ... to promote the development of rapid point-of-care tests that, ...
    (Date:9/19/2014)... Fla. , Sept. 19, 2014  The body ... with the publication of two papers this past week.  ... – Head and Neck Surgery , finds that ... and subjective measures of sleep disordered breathing, leading the ... reduction in obstructive sleep apnea severity and improvement of ...
    (Date:9/19/2014)...  CytRx Corporation (Nasdaq: CYTR ), a ... announced that David J. Haen , Vice President, ... the Biotech Industry Conference on Friday, September 26 th ... place at the Millennium Broadway Hotel in ... and archived webcast of the presentation will be available ...
    Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3
    Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
    A fusion of first class deliverability, acute angiographic results and excellent versatility....
    IVUS console...
    FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
    Medicine Products: